Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Exosomes and cancer: a newly described pathway of immune suppression.

Zhang HG, Grizzle WE.

Clin Cancer Res. 2011 Mar 1;17(5):959-64. doi: 10.1158/1078-0432.CCR-10-1489. Epub 2011 Jan 11.

2.

Exosomes and immune surveillance of neoplastic lesions: a review.

Zhang HG, Zhuang X, Sun D, Liu Y, Xiang X, Grizzle WE.

Biotech Histochem. 2012 Apr;87(3):161-8. doi: 10.3109/10520291003659042. Epub 2012 Jan 4. Review.

3.

Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments.

Taylor DD, Gercel-Taylor C.

Semin Immunopathol. 2011 Sep;33(5):441-54. doi: 10.1007/s00281-010-0234-8. Epub 2011 Jun 19. Review.

PMID:
21688197
4.

Exosomes and their roles in immune regulation and cancer.

Greening DW, Gopal SK, Xu R, Simpson RJ, Chen W.

Semin Cell Dev Biol. 2015 Apr;40:72-81. doi: 10.1016/j.semcdb.2015.02.009. Epub 2015 Feb 25. Review.

PMID:
25724562
5.

Recent advances on the role of tumor exosomes in immunosuppression and disease progression.

Filipazzi P, Bürdek M, Villa A, Rivoltini L, Huber V.

Semin Cancer Biol. 2012 Aug;22(4):342-9. doi: 10.1016/j.semcancer.2012.02.005. Epub 2012 Feb 19. Review.

6.

Cancer exosomes and NKG2D receptor-ligand interactions: impairing NKG2D-mediated cytotoxicity and anti-tumour immune surveillance.

Mincheva-Nilsson L, Baranov V.

Semin Cancer Biol. 2014 Oct;28:24-30. doi: 10.1016/j.semcancer.2014.02.010. Epub 2014 Mar 3. Review.

PMID:
24602822
7.

Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes).

Whiteside TL.

Biochem Soc Trans. 2013 Feb 1;41(1):245-51. doi: 10.1042/BST20120265. Review.

8.

[Exosomes and cancer].

de Vrij J, Maas SL, Hegmans JP, Lamfers ML, Dirven CM, Broekman ML.

Ned Tijdschr Geneeskd. 2011;155(51):A3677. Review. Dutch.

PMID:
22200143
9.

Exosomes: a novel pathway of local and distant intercellular communication that facilitates the growth and metastasis of neoplastic lesions.

Zhang HG, Grizzle WE.

Am J Pathol. 2014 Jan;184(1):28-41. doi: 10.1016/j.ajpath.2013.09.027. Epub 2013 Nov 21. Review.

10.

Cell to cell signalling via exosomes through esRNA.

Lotvall J, Valadi H.

Cell Adh Migr. 2007 Jul-Sep;1(3):156-8. Epub 2007 Jul 4. Review.

11.

Exosomes: immune properties and potential clinical implementations.

Chaput N, Théry C.

Semin Immunopathol. 2011 Sep;33(5):419-40. doi: 10.1007/s00281-010-0233-9. Epub 2010 Dec 21. Review.

PMID:
21174094
12.

Dendritic cell-derived exosomes for cancer therapy.

Pitt JM, André F, Amigorena S, Soria JC, Eggermont A, Kroemer G, Zitvogel L.

J Clin Invest. 2016 Apr 1;126(4):1224-32. doi: 10.1172/JCI81137. Epub 2016 Apr 1. Review.

13.

Exosomes and tumor-mediated immune suppression.

Whiteside TL.

J Clin Invest. 2016 Apr 1;126(4):1216-23. doi: 10.1172/JCI81136. Epub 2016 Feb 29. Review.

14.

Immune suppression: the hallmark of myeloid derived suppressor cells.

Haile LA, Greten TF, Korangy F.

Immunol Invest. 2012;41(6-7):581-94. doi: 10.3109/08820139.2012.680635. Review.

PMID:
23017136
15.

The roles of tumor-derived exosomes in cancer pathogenesis.

Yang C, Robbins PD.

Clin Dev Immunol. 2011;2011:842849. doi: 10.1155/2011/842849. Epub 2011 Nov 30. Review.

16.

Potential biomarkers of exosomal cargo in endocrine signaling.

Zduriencikova M, Gronesova P, Cholujova D, Sedlak J.

Endocr Regul. 2015 Jul;49(3):141-50. Review.

PMID:
26238497
17.

The role of placental exosomes in reproduction.

Mincheva-Nilsson L, Baranov V.

Am J Reprod Immunol. 2010 Jun;63(6):520-33. doi: 10.1111/j.1600-0897.2010.00822.x. Epub 2010 Mar 11. Review.

PMID:
20331583
18.

Harnessing the exosome-induced immune response for cancer immunotherapy.

Gehrmann U, Näslund TI, Hiltbrunner S, Larssen P, Gabrielsson S.

Semin Cancer Biol. 2014 Oct;28:58-67. doi: 10.1016/j.semcancer.2014.05.003. Epub 2014 May 22. Review.

PMID:
24859748
19.

Tumour-released exosomes and their implications in cancer immunity.

Iero M, Valenti R, Huber V, Filipazzi P, Parmiani G, Fais S, Rivoltini L.

Cell Death Differ. 2008 Jan;15(1):80-8. Epub 2007 Oct 12. Review.

20.

Negative regulation of myeloid-derived suppressor cells in cancer.

Qu P, Boelte KC, Lin PC.

Immunol Invest. 2012;41(6-7):562-80. doi: 10.3109/08820139.2012.685538. Review.

PMID:
23017135

Supplemental Content

Support Center